Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Ms. Laura Weinstein, University of Delaware, United States

Ms. Laura Weinstein is an accomplished biomedical engineering student at the University of Delaware 🎓, set to graduate in May 2025 with a stellar GPA of 3.97. With minors in nanoscale materials and chemistry 🧪, she has led impactful research in nanoparticle drug delivery, orthotic device innovation, and immunoengineering. Her work spans labs at Delaware and Vanderbilt 🏥, earning her top honors including the Eugene du Pont Memorial Scholarship and Best Poster Awards 🏆. Passionate about translational medicine, Laura’s dedication to improving healthcare through engineering solutions marks her as a rising star in biomedical research 🌟.

Publication Profile 

Google Scholar

Education

Ms. Laura Weinstein is currently pursuing an Honors Bachelor of Science in Biomedical Engineering at the University of Delaware, with expected graduation in May 2025 📅. She maintains an outstanding GPA of 3.97 🌟 and complements her major with minors in Nanoscale Materials and Chemistry ⚗️. Her coursework spans core sciences and advanced engineering, including Introductory Biology 🧬, General Chemistry 🧪, Physics ⚛️, and Biomedical Experimental Design 📊. She has also delved into Immunoengineering, Cell Engineering 🧫, Nanomaterials, and Nanomedicine 💉. Proficient in Python and MATLAB 💻, Laura combines technical skills with scientific curiosity, preparing her for groundbreaking biomedical research 🔬.

Awards

Ms. Laura Weinstein has received numerous prestigious honors throughout her academic journey. From 2021–2025, she was awarded the esteemed Eugene du Pont Memorial Scholarship 🎓, covering full tuition, housing, meals, and book expenses. In 2024, she earned 1st place for designing a prototype to secure thoracostomy tubes 🩺. She is also a National Cyber Scholar (2022–2024) 💻 and won the Biomedical Engineering Distinguished Sophomore Award in 2023 🧬. That same year, she was recognized by the Delaware Department of Technology and Information 📡. In 2022, she placed 1st in the Ratcliffe Eco Entrepreneurship Innovation Sprint 🌱🚀

Experience

Ms. Laura Weinstein has been actively engaged in cutting-edge research at the University of Delaware’s Day Lab since January 2022 🏛️. Under the mentorship of Dr. Emily Day and PhD candidate Eric Sterin 👩‍🏫, she developed polymeric nanoparticles for biomimetic cargo delivery via cancer cell membranes 🧫. She contributed to refining purification protocols for DiD-fluorescent nanoparticles 💡 and guided fellow undergraduates in research techniques 📘. Her dedication extended beyond semesters, participating in multiple research fellowships and programs including the 2022 CBER Summer Scholars REU, 2023 Winter Fellowship, and 2024–2025 Summer/Winter Fellowships 🧪📊—highlighting her passion for biomedical innovation.

Research Focus

Ms. Laura Weinstein focuses her research in the dynamic field of biomedical nanotechnology and targeted drug delivery 🧪. Her studies explore cell biomimicry, using cancer cell membranes to improve therapeutic delivery for hematological cancers 🧫🩸. She also investigates nanoparticle purification challenges, ensuring enhanced precision in drug transport systems 🎯. Her work integrates principles of nanomedicine, immunoengineering, and materials science to develop innovative approaches in cancer treatment and diagnostics 🧬. Through her publications and lab experience, Laura contributes to advancing next-generation polymeric nanoparticle technologies—blending engineering and biology to revolutionize patient care and medical outcomes 🚀💊.

Publication Top Notes

Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes

Standard purification methods are not sufficient to remove micellular lipophilic dye from polymer nanoparticle solution

Ali Olad | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ali Olad | Drug Delivery Systems | Best Researcher Award

Prof Ali Olad, University of Tabriz, Iran

Prof. Ali Olad is a distinguished researcher in applied chemistry, specializing in polymer composites, conducting polymers, and polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (2003) from the University of Tabriz, where he continues to teach courses on industrial chemistry, polymer nanocomposites, and coatings. 📚 His research focuses on nanocomposites, conducting polymers, corrosion resistance, and environmental pollutant detection. 🌱🧪 Prof. Olad has presented groundbreaking work globally, authored influential books, published high-impact papers, and holds patents on polyaniline nanostructures and advanced materials. 🏆💡 His innovations in hydrogels, fertilizers, and sensors reflect his commitment to sustainable and practical chemical solutions. 🌍✨

Publication Profile

Google Scholar

Educational Background

Prof. Ali Olad is a distinguished academic specializing in Applied Chemistry, with a focus on polymer composites, conducting polymers, and corrosion-resistant polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (Polymer Composites & Conducting Polymers) from the University of Tabriz, Iran, in 2003. 📘 Prior to this, he completed his M.Sc. in Applied Chemistry (Corrosion & Polymeric Coatings) in 1997 and his B.Sc. in Applied Chemistry in 1995, both from the same institution. 🔬 His expertise and academic achievements contribute significantly to advancements in materials science, fostering innovative research and practical applications in the field. 🌟

Experience

Prof. Ali Olad has a remarkable teaching career at the University of Tabriz, offering diverse courses across various academic levels. He has taught Conducting Polymers at the Ph.D. level (2006–2010) and Industrial Chemistry 2 at the B.Sc. level since 1997. Additionally, he lectured on Industrial Electrochemistry (2003–2017). Prof. Olad continues to teach Coatings and Adhesives (Ph.D.), Polymer Composites and Nanocomposites (M.Sc.), and Physical and Mechanical Properties of Polymers (M.Sc.) since 2010. His dedication to education and expertise in polymers, nanocomposites, and industrial chemistry have greatly contributed to the field. 🎓📚🧪✨

Research Interests

Prof. Ali Olad specializes in the fields of polymer composites and nanocomposites, focusing on their development and applications. His expertise extends to surface modification and polymer coatings, enhancing material performance. Additionally, he works on conducting polymers and blends, exploring their conductive properties. Prof. Olad’s research also delves into polymer hydrogels, investigating their potential in various biomedical and industrial applications. Furthermore, he studies corrosion and electrochemistry, aiming to improve material durability and sustainability. His contributions to these areas have led to advancements in materials science and engineering. 🌐🔬🧪💡🛠️

Research Focus

The individual behind these publications appears to have a research focus in materials science, environmental engineering, and nanocomposites, with particular attention to polymers, hydrogel systems, and waste treatment technologies. Their work spans a range of topics such as electrocoagulation for dye removal, slow-release fertilizers, and anti-corrosion coatings, with an emphasis on nanocomposite materials like clay-polymers, superabsorbent hydrogels, and conductive polymers. This person is also involved in environmental cleanup and water treatment, exploring methods to improve water quality by utilizing advanced materials and nanotechnology 🧪🌍💧🔬.

Publication Top Notes

Decolorization of basic dye solutions by electrocoagulation: An investigation of the effect of operational parameters

Slow-released NPK fertilizer encapsulated by NaAlg-g-poly (AA-co-AAm)/MMT superabsorbent nanocomposite

Anti-corrosive properties of polyaniline coating on iron

Slow-release NPK fertilizer encapsulated by carboxymethyl cellulose-based nanocomposite with the function of water retention in soil

Polymer-clay nanocomposites

Superabsorbent hydrogel made of NaAlg-g-poly (AA-co-AAm) and rice husk ash: Synthesis, characterization, and swelling kinetic studies

On the preparation and swelling properties of hydrogel nanocomposite based on Sodium alginate-g-Poly (acrylic acid-co-acrylamide)/Clinoptilolite and its …

Removal of chromium from aqueous solution using polyaniline–poly ethylene glycol composite

Optimization of electrocoagulation process for removal of an azo dye using response surface methodology and investigation on the occurrence of destructive side reactions

Preparation and anticorrosive properties of PANI/Na-MMT and PANI/O-MMT nanocomposites

The synergetic effect of bioactive ceramic and nanoclay on the properties of chitosan–gelatin/nanohydroxyapatite–montmorillonite scaffold for bone tissue engineering

 

 

 

 

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Published on by Top Pharmaceutical

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. 🏅🔬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 🎓. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements 💊. With leadership roles in major hospitals 🏥 and an esteemed position as a professor at Fukuyama University 🎓, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes 🌍🔬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization 💊🔬. His research focuses on infection control 🦠, renal function-based dosing 🏥, and improving prescription practices, directly enhancing patient safety and treatment efficacy 👨‍⚕️✅. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide 🌍💉.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 🏆, as well as the esteemed Academic Contribution Award in 2014 🎓. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. 🧪💊

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats

 Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant

Dosage adjustment of dabigatran etexilate based on creatinine clearance in patients with cardioembolic stroke or atrial fibrillation

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

 

Prof.Aleksandr Urakov|Drug Repurposing | Best Researcher Award

Published on by Top Pharmaceutical

Prof.Aleksandr Urakov, Drug Repurposing ,Best Researcher Award

Prof.Aleksandr Urakov atIzhevsk State Medical Academy,Russia

PROFILE  

scopus

Orcid

Academic Leadership 🏫

Professor Aleksandr Urakov serves as the head of the Department of General and Clinical Pharmacology at Izhevsk State Medical Academy. His leadership has been instrumental in shaping the department into a center of excellence in pharmacological research and education.

Innovative Contributions 🧠

As an inventor, Professor Urakov holds over 270 patents and has published more than 200 scientific articles . His research in temperature pharmacology and drug repurposing  has led to significant advancements, including the development of the floating tablet and warm alkaline hydrogen peroxide solutions .

Recognition and Honors 🎖️

For his remarkable contributions, Professor Urakov has been awarded the Order of the Badge of Honor and holds the prestigious title of Honored Inventor of the Russian Federation . His work continues to influence and inspire the medical community globally.

Research and Innovations🔬 :

Professor Urakov invented the floating tablet and discovered warm alkaline hydrogen peroxide solutions (WAHPSs), which include new drug subgroups like bruise bleaches, pus-dissolving drugs (pyolytics), and oxygen-producing antihypoxants. These innovations offer alternatives to ECMO for hypoxemia in COVID-19 asphyxia.

🎓Publication 

Comment: Balanced Salt Solutions for Critically Ill Patients: Nonplused and Back to Basics

Thermal imaging of local skin temperature as part of quality and safety assessment of injectable drugs

    • Authors :Urakov, A., Urakova, N., Samorodov, A., … Suntsova, D., Muhutdinov, N..
    • Journal   :Heliyon
    • Year       : 2024

Understanding burn injuries in children – A step toward prevention and prompt first aid

  • Authors  :Urakov, A.L., Suntsova, D.O., Yagudin, I.I.
  • Journal    :Burns
  • Year         :  2023

ASSESSMENT OF FETAL RESISTANCE TO HYPOXIA USING THE STANGE TEST AS AN ADJUNCT TO APGAR SCALE ASSESSMENT OF NEONATAL HEALTH STATUS

  • Authors  :Shabanov, P.D., Urakov, A.L., Urakova, N.A.
  • Journal   :Medicinskij Akademiceskij Zurnal,
  • Year        :   2023

Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons

Assoc Prof Dr.Guanyu Chen|Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr.Guanyu Chen, Drug Delivery Systems,Best Researcher Award

Assoc Prof Dr.Guanyu Chen, at Sun Yat-Sen University School of Pharmaceutical Sciences Shenzhen,China

PROFILE  

scopus

🧪 Research Focus :

Associate Prof. Guanyu Chen is an expert in Drug Delivery and Immunochemotherapy at the School of Pharmaceutical Sciences, Sun Yat-sen University.

🎓 Education and Professional Experience :

He earned his Bachelor’s (2005-2008), Master’s (2009-2012), and PhD (2012-2016) degrees from the University of Auckland, New Zealand. Following his PhD, he worked as a Postdoctoral Fellow at the same university from 2017 to 2019. During this time, he also served as a Research Assistant at Ancare Scientific Ltd, Douglas Ltd, Alleva Animal Health Ltd, and Kimberly Clack Ltd. In 2019, he joined Sun Yat-sen University, China, as an Associate Professor.

💰 Research Funding :

Prof. Chen has received significant funding for his research, including the National Natural Science Foundation of China in 2022 (82273871), the Guangdong Basic and Applied Basic Research Foundation in 2021 (2021A1515110006), the Shenzhen Science and Technology Program in 2020 (GXWD20201231165807008), the 67th Batch Postdoc Research Foundation of China in 2019 (2020M673030), and the Kimberly Clarks Pharmaceutics Research Fund, USA in 2016 (32715.001).

🏅 Patents and Awards :

His achievements include two national invention patents and several prestigious awards: Overseas Senior Talent of Shenzhen, Recruiting Outstanding Overseas Talent of Guangdong, Maurice and Phyllis Paykel Research Award, Academic Career Exploration Scholarship, Edna and Denis Moloney Scholarship, FMHS-PGSA Award from the University of Auckland, Elite Editing Thesis Write-up Scholarship from Australia, and The University of Auckland Partnership Appeal Award.

📚 Editorial Roles :

Prof. Chen contributes to the academic community as a Youth Editorial Board Member for Acta Materia Medica and the Journal of Drug Delivery and Translational Research. He also serves as a Guest Editor for the Journal of Current Drug Delivery and Pharmaceutics.

🔍 Conclusion

Associate Prof. Guanyu Chen stands out as a leading researcher in drug delivery and immunochemotherapy, with a robust academic background and extensive experience. His significant contributions to the field are supported by notable research funding and a series of prestigious awards. As a dedicated academic and editorial contributor, Prof. Chen continues to advance pharmaceutical sciences through his research, mentorship, and publication efforts.

🎓Publication 

The scaffold protein AXIN1: gene ontology, signal network, and physiological function

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis

Cryo-Milled β-Glucan Nanoparticles for Oral Drug Delivery

  • Authors  :Chen, G., Liu, Y., Svirskis, D., … Lu, W., Wen, J.
  • Journal    :Pharmaceutics
  • Year         :  2024

Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy

Development of a novel peptide targeting GPR81 to suppress adipocyte-mediated tumor progression

  • Authors  :Chen, S., Zhou, X., Li, W., … Liu, J., Gao, Y.
  • Journal   :Biochemical Pharmacology
  • Year        :  2023